‘I am delighted that we have been able to gain Heinlein Plastik-Technik, which is a long-established, global business,’ says ALPLA CEO Philipp Lehner in summary, upon successfully concluding the negotiations. ‘It is a good fit with our focus on the one hand on the dynamics of advancing technological innovations and on the global expansion of our business activities on the other. With the extensive know-how that Heinlein has to offer, we can expand our product portfolio to include high-quality primary packaging solutions for the pharma industry. The beneficiaries of this will first and foremost be our mutual customers, who will now be able to source their tailored system solutions from a single place.’
‘With Heinlein Plastik-Technik at our side, our capacities in the area of injection moulding will now considerably increase once again,’ adds Walter Knes, Managing Director of ALPLApharma: ‘We additionally plan to turn the Ansbach site into a technology centre for injection moulding and automation technology for the entire ALPLApharma group.’
Saskia Wellhöfer-Meyer, owner and CEO of Heinlein Plastik-Technik, sees the acquisition as the perfect opportunity to systematically further develop the company’s site: ‘We look forward to applying our broad expertise in the development and production of precision closure and dosing systems. I firmly believe that, as we continue to operate largely independently as a “Member of ALPLApharma”, we will henceforth be in an even better position to cater to the market demand for comprehensive, high-quality and competitively priced system solutions.’
